trinitrate (nitroglycerin) is partly attributed to its action on hemodynamics.1) Glyceryl trinitrate has been known to reduce preload to the heart, i.e. venous return2) besides its effect of reducing the afterload i.e. peripheral vascular resistance. This sequence has led to the conception of unloading therapy of heart failure with vasodilator drugs.3) On the other hand, vasodilators may cause a drastic hypotension by an excessive use, by the effect on peripheral vasculature, as is often the case, combined with cardiodepressant effect. Moreover, Kokubun et al4) and Imai et al5) showed that various calcium antagonistic vasodilators, dilazep, diltiazem, D 600, nifedipine, prenylamine, SK & F 24260, and trimethazidine, increased venous return (VR) and cardiac output of anesthetized dogs except at excessive doses which caused obvious cardiac depression.
Perhexiline, 2-(2,2-dicyclohexylethyl) piperidine, is a recently developed vasodilator that has been reported useful in treatment of angina pectoris6) and that is classified in calcium antagonists.7) We have studied the pharmacology of perhexiline and have reported some interesting features of it.8)-12) In this paper we describe the cardiohemodynamic effects of perhexiline in anesthetized open-chest dogs including some analyses of the effects.
METHODS
Experiments were carried out essentially according to the methods of Kokubun et al.4) Mongrel dogs of either sex weighing 8.5-12.5Kg were anesthetized with intravenous pentobarbital sodium initially of 30mg/Kg and subsequently with hourly supplement of 3-5mg/Kg to maintain an adequate level of anesthesia. Mechanical respiration was performed with a Harvard respirator through the intubated trachea. Thorax was opened by mid-sternotomy and the heart was positioned in the pericardial cradle. Probes of non-cannulating type for electromagnetic flowmeters (Narco, RT500) were attached to the superior and inferior venae cavae and to the pulmonary trunk. The azygos vein was ligated. Interactions among these flowmeters were minimized by adjusting the phase of magnetizing current through the three flowmeters. Right atrial pressure was measured by a cannula inserted into the auricle with a pressure transducer (Statham, P23BB) and systemic blood pressure at the femoral artery with a Statham P23Db transducer through carrier amplifiers (San-ei Sokki, 1206B) assembled in a polygraph (San-ei Sokki, 142-8). Heart rate was measured from ECG with a tachometer (DataGraph, T-149) which displayed the rate per minute beat by beat digitally and put out analog signals for the recorder. These parameters were recorded on inkwriting rectilinear recorders (San-ei Sokki, Recti-Horiz 8S-53).
Drugs used in this study were: 1-norepinephrine (Fluka), perhexiline hydrochloride (Merrell), phentolamine mesylate (Ciba), dl-propranolol hydrochloride (Sigma), and dl-verapamil hydrochloride (Eisai). Perhexiline and verapamil were dissolved in distilled water and injected slowly over 2min, to avoid drastic effects by a bolus injection.8) All the doses refer to their bases. Statistical analyses were made according to Student's t-test.
RESULTS
Three electromagnetic flowmeters, probes of which were in close proximity interacted on each other to alter the measurements by up to 5%, even though the interactions were minimized as described in Methods.
The right ventricular output or the blood flow rate of the pulmonary artery (PAF), however, showed fairly good accordance with the venous return (VR) or the sum of blood flow rates of the superior and inferior venae cavae. ml/min in the beginning of the measurements.
As the experiments proceeded, however, both values tended to decline and the discrepancy between these two values enlarged perhaps from impairment of tight contact of a flowmeter probe to the vessel wall.
Intravenous administration of 0.3-3mg/Kg of perhexiline increased PAF and VR in a tolerably dose-dependent manner. Increases in PAF and VR were in good temporal correlation, both had the peak at 2-3min from the initiation of injection and returned to the control level within 5-6min and then usually showed decreases. Extent of increases in PAF and VR was not so remarkable and reached about 20% with 3mg/Kg of perhexiline. Systemic blood pressure (SBP) and heart rate (HR) decreased with perhexiline dose-dependently, though in a few cases slight increases intervened. Right atrial pressure (RAP) was increased with perhexiline. A typical experimental record is illustrated in Fig. 1 and the summarized data are shown in Fig.2 .
Verapamil, 0.03-0.3mg/Kg injected over 2min, initially increased and later decreased RAF and VR. Dose-dependency in these effects was not plain as decreases became greater than increases with the higher dose. SBP and HR uniformly decreased and RAP increased with verapamil dose-dependently. A typical experiment is shown in Fig. 3 . Effects of autonomic blockade on the hemodynamic effects of perhexiline were analyzed and shown in Fig. 4 . Treatment with 1mg/Kg of propranolol decreased PAF (by 18%), SBP (by 17%), HR (by 26%), and VR (by 36%), and increased RAP (by 90%). Effects of norepinephrine on PAF and HR were blocked by propranolol and these showed steep decreases secondary to an increase of SBP. Increase of VR with was not blocked by 1mg/Kg of propranolol, though it was somewhat attenuated. Effects of perhexiline to increase VR and PAF were not blocked with the propranolol treatment. Intravenous phentolamine, 1mg/Kg, administered to the dog pretreated with propranolol, further decreased SBP (by 26%) and HR (by 7%), also decreased VR (by 16%), PAF (by 16%), and RAP (by 21%) after short-lasting increases, and completely blocked In the succeeding study,5) they investigated further the cardiohemodynamic effects of other Cat+-antagonistic vasodilators, D 600, dilazep, diltiazem, SK & F 24260, and trimethazidine and obtained a common pharmacological feature of these drugs that they produced slight increases followed by decreases in venous return and cardiac output except for SK & F 24260 which markedly increased them. Increase of pulmonary arterial flow with perhexiline is explained by increase of venous return.
A slight increase in systemic cardiac output was also observed when aortic blood flow was measured (unpublished observation).
A slight positive inotropic action was observed with relatively low doses of perhexiline in a papillary muscle preparation of the dog perfused with blood.9) This action may also participate in its effect in increasing cardiac output. 
